P

PTC Therapeutics
D

PTCT

50.680
USD
0.30
(0.60%)
مغلق
حجم التداول
8,115
الربح لكل سهم
3
العائد الربحي
-
P/E
-9
حجم السوق
3,908,702,247
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABUS
    -0.01500
    (-0.44%)
    3.42500 USD
    A
    ARCT
    0.846
    (5.00%)
    17.770 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    C
    CRNX
    0.660
    (1.79%)
    37.470 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    G
    GLPG
    0.055
    (0.21%)
    26.765 USD
    R
    RARE
    -1.920
    (-4.31%)
    42.590 USD
    S
    SLDB
    -0.22000
    (-3.67%)
    5.77500 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    V
    VYGR
    -0.04000
    (-0.94%)
    4.22500 USD
    المزيد
الأخبار
المقالات

العنوان: PTC Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.